Literature DB >> 8726254

Dispase/detergent treated dermal matrix as a dermal substitute.

Y Takami1, T Matsuda, M Yoshitake, M Hanumadass, R J Walter.   

Abstract

A method for preparing acellular allogeneic dermal matrix (ADM) and its effectiveness as a dermal substitute are described. Treatment of rat skin with Dispase followed by Triton X-100 completely removed cellular components from the dermis. Subcutaneously implanted ADM evoked no immunological reaction and 20 weeks after implantation, the size of the implanted ADM was reduced to about 60 per cent of its original area. ADM became completely vascularized within 2 weeks after implantation into full thickness skin defects in the rat and inhibited extensive wound contracture. A second layer of ADM placed onto the implanted ADM served as an excellent dressing, providing mechanical protection and permitting vascularization of the underlying implant. Onlay skin autografts placed onto vascularized allogeneic ADM showed good survival when the skin was grafted more than 1 week after ADM implantation. Dispase/detergent treated ADM derived from animal or human skin may be useful in full thickness skin defects providing a vascularized bed for subsequent epidermal coverage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726254     DOI: 10.1016/0305-4179(95)00123-9

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  10 in total

1.  Application of acellular dermal matrix for intestinal elongation in animal models.

Authors:  Hui-Min Xu; Zhen-Jun Wang; Jia-Gang Han; Hua-Chong Ma; Bo Zhao; Bao-Cheng Zhao
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

2.  Use of porcine acellular dermal matrix as a dermal substitute in rats.

Authors:  A Srivastava; E Z DeSagun; L J Jennings; S Sethi; A Phuangsab; M Hanumadass; H M Reyes; R J Walter
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

3.  Autologous skin reconstruction by combining epidermis and acellular dermal matrix tissue derived from the skin of giant congenital melanocytic nevi.

Authors:  Pham Hieu Liem; Naoki Morimoto; Ran Ito; Katsuya Kawai; Shigehiko Suzuki
Journal:  J Artif Organs       Date:  2013-05-05       Impact factor: 1.731

4.  Evaluation of dermal substitute in a novel co-transplantation model with autologous epidermal sheet.

Authors:  Guofeng Huang; Shizhao Ji; Pengfei Luo; Yunqing Zhang; Guangyi Wang; Shihui Zhu; Shichu Xiao; Zhaofan Xia
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  Comparison of dermal substitutes in wound healing utilizing a nude mouse model.

Authors:  Anh-Tuan N Truong; Areta Kowal-Vern; Barbara A Latenser; Dorion E Wiley; Robert J Walter
Journal:  J Burns Wounds       Date:  2005-03-14

Review 6.  Acellular dermal matrices and radiotherapy in breast reconstruction: a systematic review and meta-analysis of the literature.

Authors:  Luigi Valdatta; Anna Giulia Cattaneo; Igor Pellegatta; Stefano Scamoni; Anna Minuti; Mario Cherubino
Journal:  Plast Surg Int       Date:  2014-05-21

7.  Dermis, acellular dermal matrix, and fibroblasts from different layers of pig skin exhibit different profibrotic characteristics: evidence from in vivo study.

Authors:  Yanhai Zuo; Shuliang Lu
Journal:  Oncotarget       Date:  2017-04-04

8.  Free ureteral replacement in rats: regeneration of ureteral wall components in the acellular matrix graft.

Authors:  S E Dahms; H J Piechota; L Nunes; R Dahiya; T F Lue; E A Tanagho
Journal:  Urology       Date:  1997-11       Impact factor: 2.649

9.  Regeneration of mature dermis by transplanted particulate acellular dermal matrix in a rat model of skin defect wound.

Authors:  Haibin Zuo; Daizhi Peng; Bixiang Zheng; Xiaoling Liu; Yong Wang; Lihua Wang; Xin Zhou; Jing Liu
Journal:  J Mater Sci Mater Med       Date:  2012-08-19       Impact factor: 3.896

10.  Application of an acellular dermal matrix to a rabbit model of oral mucosal defects.

Authors:  Xiangliang Xu; Nianhui Cui; Enbo Wang
Journal:  Exp Ther Med       Date:  2018-01-05       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.